Home/Project news/PREV_PKDL project strengthens flow cytometry capacity in Africa
The PREV_PKDL project aims to advance the clinical development of ChAd63-KH vaccine for the prevention of post kala azar dermal leishmaniasis (PKDL). One of activities of the project is strengthening immunology research capacity in East Africa by promoting the development of a flow cytometry Centre of Excellence. Flow cytometry is a powerful tool with applications in multiple disciplines such as immunology, virology, molecular biology, cancer biology and infectious disease monitoring. Flow cytometers were installed at four African sites: Institute of Endemic Diseases (IEND), Sudan; Kenya Medical Research Institute (KEMRI), Kenya; University of Gondar, Ethiopia; University of Makerere, Uganda.